CJ
Cecilia Jones (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Agios Pharmaceuticals, Inc. (AGIO). The largest single filing was $109K of AGIO (3,141 sh × $34.71, as filed), executed Apr 2. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$109K
shares × price, as filed
Last traded
Apr 2
Filed Apr 6
Median ADV $39.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $243K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
AGIORecent filings
AGIOSALE
Agios Pharmaceuticals, Inc.
View filing →
$109K3,141 sh × $34.71
Exec Apr 2
Filed Apr 6 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. View filing → $134K
3,651 sh × $36.77
Exec Sep 26 2025
Filed Sep 30 2025 · 5:30 PM ET